Literature DB >> 23691802

[Treatment of psychiatric symptoms in schizophrenia spectrum disorders with comorbid sleep apnea syndrome: a case report].

Toshiaki Hiraoka1, Naoto Yamada.   

Abstract

Sleep apnea syndrome (SAS) is characterized by apnea and hypopnea during sleep. SAS manifests various symptoms, and can become a risk factor for a variety of diseases. Typical psychiatric presentations of SAS are depressive symptoms, and those resembling negative symptoms in schizophrenia. We report two patients with schizophrenia spectrum disorders. Both patients showed the partial improvement of psychiatric symptoms with pharmacotherapy. After diagnosing comorbid SAS and subsequent treatment with continuous positive airway pressure (CPAP), the psychiatric symptoms improved. The first case was a 54-year-old woman, who presented with auditory hallucinations and delusions and was diagnosed with schizophrenia at 32 years of age. Her positive symptoms responded immediately to medication; however, her negative symptoms persisted despite switching to atypical antipsychotics. We diagnosed her with SAS using pulse oximetry and portable polysomnography (PSG), and, after treatment with CPAP, her fatigue and shallow sleep improved, as well as her quality of life (QOL). The second case was is a 61-year-old man, who presented with delusions of persecution and was diagnosed with delusional disorder at 49 years of age. His delusional symptoms fluctuated under medication, and repeatedly worsened under stressful situations. We suspected SAS as a Complicating factor, and diagnosed him with severe SAS using PSG. After treatment with CPAP, his hypertension and delusions of persecution improved. Screening for SAS is available in psychiatric hospitals and outpatient clinics. We believe that the possibility of comorbid SAS in psychiatric patients should be more widely acknowleged in clinical psychiatry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23691802

Source DB:  PubMed          Journal:  Seishin Shinkeigaku Zasshi        ISSN: 0033-2658


  3 in total

1.  Positive Airway Pressure Adherence in Patients with Obstructive Sleep Apnea with Schizophrenia.

Authors:  Marwan Saoud; Musa Saeed; Sumit Patel; M Jeffery Mador
Journal:  Lung       Date:  2019-12-10       Impact factor: 2.584

2.  Obstructive Sleep Apnea Is Treatable With Continuous Positive Airway Pressure in People With Schizophrenia and Other Psychotic Disorders.

Authors:  Jamilla J Giles; Ivan Ling; Nigel McArdle; Romola S Bucks; Gemma Cadby; Bhajan Singh; Vera A Morgan; Laura Gabriel; Flavie Waters
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

3.  Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Ping Ma; Bradley G Phillips
Journal:  Sleep Breath       Date:  2020-10-09       Impact factor: 2.816

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.